These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9789720)

  • 21. Clinical experience with acarbose: results of a Canadian multicentre study.
    Rodger NW; Chiasson JL; Josse RG; Hunt JA; Palmason C; Ross SA; Ryan EA; Tan MH; Wolever TM
    Clin Invest Med; 1995 Aug; 18(4):318-24. PubMed ID: 8549019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of Acarbose in Type 2 diabetic patients in secondary failure: effects on glycaemic control and diet induced thermogenesis.
    Brooks B; Molyneaux L; Zilkens R; Ross G; Yue DK
    Diabetes Res Clin Pract; 1998 Dec; 42(3):175-80. PubMed ID: 9925348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year acarbose treatment raises fasting serum acetate in diabetic patients.
    Wolever TM; Radmard R; Chiasson JL; Hunt JA; Josse RG; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH
    Diabet Med; 1995 Feb; 12(2):164-72. PubMed ID: 7743764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acarbose and insulin therapy in type I diabetes mellitus.
    Rios MS
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():36-9. PubMed ID: 8001626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A risk-benefit appraisal of acarbose in the management of non-insulin-dependent diabetes mellitus.
    Santeusanio F; Compagnucci P
    Drug Saf; 1994 Dec; 11(6):432-44. PubMed ID: 7727053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acarbose: in search for its real indications in current medical practice.
    Lerman I; Gómez Perez FJ; Aguilar-Salinas CA; Rodrigo JA
    Diabetes Care; 1996 Jan; 19(1):94-5. PubMed ID: 8720547
    [No Abstract]   [Full Text] [Related]  

  • 27. Beneficial effects on serum lipids in noninsulin dependent diabetics by acarbose treatment.
    Leonhardt W; Hanefeld M; Fischer S; Schulze J; Spengler M
    Arzneimittelforschung; 1991 Jul; 41(7):735-8. PubMed ID: 1772463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.
    Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH; Wolever TM
    Ann Intern Med; 1994 Dec; 121(12):928-35. PubMed ID: 7734015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study.
    Riccardi G; Giacco R; Parillo M; Turco S; Rivellese AA; Ventura MR; Contadini S; Marra G; Monteduro M; Santeusanio F; Brunetti P; Librenti MC; Pontiroli AE; Vedani P; Pozza G; Bergamini L; Bianchi C
    Diabet Med; 1999 Mar; 16(3):228-32. PubMed ID: 10227568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safe and effective treatment of diabetes mellitus associated with chronic liver diseases with an alpha-glucosidase inhibitor, acarbose.
    Kihara Y; Ogami Y; Tabaru A; Unoki H; Otsuki M
    J Gastroenterol; 1997 Dec; 32(6):777-82. PubMed ID: 9430016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PROTECT interim results: a large multicenter study of patients with type II diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies.
    Baron A; Neumann C
    Clin Ther; 1997; 19(2):282-95. PubMed ID: 9152567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate.
    Wolever TM; Chiasson JL; Josse RG; Hunt JA; Palmason C; Rodger NW; Ross SA; Ryan EA; Tan MH
    Diabetes Care; 1998 Oct; 21(10):1612-8. PubMed ID: 9773719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acarbose for the treatment of type II diabetes: the results of a Canadian multi-centre trial.
    Josse RG
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S167-72. PubMed ID: 8529510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of acarbose and gliclazide as first-line agents in patients with type 2 diabetes.
    Salman S; Salman F; Satman I; Yilmaz Y; Ozer E; Sengül A; Demirel HO; Karşidağ K; Dinççağ N; Yilmaz MT
    Curr Med Res Opin; 2001; 16(4):296-306. PubMed ID: 11268714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between acarbose, metformin, and insulin treatment in type 2 diabetic patients with secondary failure to sulfonylurea treatment.
    Calle-Pascual AL; Garcia-Honduvilla J; Martin-Alvarez PJ; Vara E; Calle JR; Munguira ME; Marañes JP
    Diabete Metab; 1995 Oct; 21(4):256-60. PubMed ID: 8529760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of long term acarbose (Bay g 5421) therapy on metabolic control of non insulin dependent (type II) diabetes mellitus.
    Rodier M; Richard JL; Monnier L; Mirouze J
    Diabete Metab; 1988; 14(1):12-4. PubMed ID: 3292303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of poorly controlled non-insulin-dependent diabetic patients with Acarbose.
    Scott RS; Knowles RL; Beaven DW
    Aust N Z J Med; 1984 Oct; 14(5):649-54. PubMed ID: 6397178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy.
    Standl E; Baumgartl HJ; Füchtenbusch M; Stemplinger J
    Diabetes Obes Metab; 1999 Jul; 1(4):215-20. PubMed ID: 11228756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical effectiveness of Novolin® 30R versus Lantus® combined with Glucobay® treatment in elderly patients with type 2 diabetes mellitus controlled by oral hypoglycaemic agents: A randomized study.
    Sun Y; Shao L; Niu X; Liu Y; Ge J; Jiang H; Zhang H
    J Int Med Res; 2014 Aug; 42(4):993-1001. PubMed ID: 24925584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.